Revolutionizing Targeted Therapeutics: Akari Therapeutics and Peak Bio Unveil Portfolio Prioritization Plan for Post-Merger Entity
Akari Therapeutics and Peak Bio Join Forces in Strategic Merger, Prioritizing ADC Technology and GA ProgramBOSTON and PLEASANTON, Calif., May 01, 2024 - Akari Therapeutics, Plc (Nasdaq: AKTX, Akari) and Peak Bio Inc. (O...
May 1, 2024
• Biotechnology & Pharmaceuticals Industry
Merger and Acquisition
Akari Therapeutics Plc
